US CANNABIS LAWS
Medical cannabis legal since 2021 — recreational still illegal. Here’s everything residents and visitors need to know about Alabama’s weed laws.
Alabama is a medical-only state. The Darren Wesley Ato Hall Compassion Act — named after a Birmingham pastor and cannabis advocate who died of cancer in 2021 — was signed by Governor Kay Ivey in May 2021. It created a framework for licensed dispensaries, cultivators, and processors overseen by the Alabama Medical Cannabis Commission (AMCC).
Implementation faced significant delays due to licensing disputes and legal challenges. The AMCC did not issue final operational licenses until late 2023, and the first dispensaries began selling products to registered patients in 2024. Alabama remains one of the more conservative Southern states on cannabis policy, and no serious recreational legalization effort is expected in the near term from the Republican-controlled legislature.
For non-patients, cannabis remains a Schedule I controlled substance under Alabama law. There is no decriminalization for recreational possession — even small amounts carry criminal penalties.
Alabama’s possession laws are among the stricter in the South. There is no civil penalty or decriminalization tier — any recreational possession triggers a criminal charge.
| Amount | Charge | Max Penalty |
|---|---|---|
| Under 2 oz (first offense) | Class A Misdemeanor | 1 year / $6,000 |
| Under 2 oz (repeat offense) | Class D Felony | 1–5 years / $7,500 |
| Over 2 oz | Class D Felony (possession) | 1–5 years |
| Sale / distribution | Class B or A Felony | 2–20 years |
| Medical patient (within program limits) | Legal | No penalty |
Note: Alabama uses a sentence enhancement system. Prior drug convictions significantly increase potential sentences. Possession near schools or housing projects carries additional mandatory minimums.
The Alabama Medical Cannabis Commission regulates every aspect of the state’s medical program — from grower and processor licenses to dispensary permits and patient registration. The program allows qualified patients to purchase specific cannabis products from licensed dispensaries but does not permit home cultivation.
| Qualifying Condition | Notes |
|---|---|
| Cancer | Including chemotherapy side effects |
| Epilepsy / seizure disorders | Including intractable epilepsy |
| Chronic pain | Persistent and debilitating |
| PTSD | Post-traumatic stress disorder |
| ALS | Amyotrophic lateral sclerosis |
| Crohn’s disease | Inflammatory bowel condition |
| Depression / anxiety | When other treatments have failed |
| HIV/AIDS | Including wasting syndrome |
| Parkinson’s disease | Qualifying neurological condition |
| Sickle cell anemia | Certified by physician |
| Spasticity | Including MS-related spasticity |
| Terminal illness (physician-certified) | With 12-month prognosis |
Patients must obtain a written certification from an AMCC-registered physician, then apply through the AMCC patient portal. The card must be renewed annually. Caregivers can also be registered to assist qualifying patients who cannot access dispensaries themselves.
Alabama legalized industrial hemp and hemp-derived CBD products in 2019 through SB 46. This aligns with the federal 2018 Farm Bill, which removed hemp (defined as cannabis with 0.3% THC or less) from the Controlled Substances Act. CBD oils, capsules, topicals, and edibles derived from compliant hemp are sold legally throughout Alabama.
Products must contain 0.3% delta-9 THC or less to be sold legally outside the medical cannabis program. The Alabama Department of Agriculture and Industries oversees hemp cultivation licensing for in-state growers. Delta-8 THC derived from hemp exists in a legal grey area; retail availability varies by county and retailer.
Alabama’s political landscape makes near-term recreational legalization unlikely. The state legislature is dominated by Republicans who have historically opposed broader cannabis reform. The Hall Compassion Act passed after years of advocacy and was specifically framed as a compassionate medical measure rather than a reform of drug policy.
Alabama does not allow citizen-initiated ballot measures, meaning any future legalization would require legislative action. Polling shows growing support for medical cannabis but more modest backing for recreational legalization compared to national averages. The success of the medical program — including tax revenue and patient outcomes — may eventually shift the political calculus, but no serious recreational bill has been introduced as of 2026.
Neighboring states like Mississippi (medical) and Georgia (CBD-only with limited medical) reflect the conservative regional trend. Florida’s failed 2024 recreational ballot measure signals headwinds for Deep South legalization efforts.
| State | Small Possession Penalty | Medical Program | Recreational |
|---|---|---|---|
| Alabama | Class A misdemeanor | Yes (2021) | Illegal |
| Mississippi | $250 civil fine (decrim) | Yes (2022) | Illegal |
| Georgia | Misdemeanor / varies by city | Limited (CBD only) | Illegal |
| Tennessee | Class A misdemeanor | No | Illegal |
| Florida | First offense up to $1,000 / 1 year | Yes (robust) | Illegal (Amend 3 failed 2024) |
The process for registering as a medical cannabis patient in Alabama involves several steps. First, you must schedule an appointment with a physician who is registered with the Alabama Medical Cannabis Commission (AMCC). The physician will evaluate whether you have one of the 12 qualifying conditions and, if so, provide a written certification.
Once you have the certification, you apply online through the AMCC patient portal at amcc.alabama.gov. You will need to submit identification, proof of Alabama residency, and the physician certification. The application fee is $65, with a reduced fee of $10 for low-income patients. The card is valid for one year and must be renewed annually.
Caregivers — family members or designated individuals who assist patients who cannot access dispensaries themselves — can also be registered through the AMCC portal. A caregiver can serve up to five patients simultaneously.
Alabama’s medical cannabis law permits a range of product types. Licensed dispensaries in Alabama can sell:
Notably, Alabama does permit non-combusted cannabis flower — meaning patients can purchase and vaporize dry herb, but smoking is not permitted. This is a relatively broad product menu compared to states like Iowa and West Virginia, which have stricter form restrictions.
Educational overview of Alabama’s medical cannabis program, AMCC registration, and patient rights.
Despite Alabama’s medical cannabis program, the state does not require employers to accommodate medical cannabis users. Employers in Alabama retain the right to maintain drug-free workplace policies and to test employees and applicants for cannabis. A positive test result — even for a registered medical patient — can be grounds for termination or rejection of a job application.
Federal contractors and employers subject to federal drug-free workplace regulations have no flexibility on this point, as cannabis remains a Schedule I substance under federal law. State and local government employers in Alabama similarly are not required to accommodate medical cannabis use.
For patients concerned about employment drug testing, it is important to understand detection windows. THC can remain detectable in urine for 3–30 days depending on frequency of use, in blood for 1–7 days, and in hair follicles for up to 90 days. See our full drug test guide for state-by-state employer rules.
| State | Program Launch | Home Grow | Dispensaries |
|---|---|---|---|
| Alabama | 2021 (law) / 2024 (dispensaries) | No | ~10 licensed |
| Mississippi | 2022 (law) / 2023 (dispensaries) | No | Licensed & growing |
| Louisiana | 2015 (law) / 2019 (dispensaries) | No | 10 licensed pharmacies |
| Arkansas | 2016 (vote) / 2019 (dispensaries) | No | 40+ dispensaries |
| Florida | 2016 (vote) / 2017 (dispensaries) | No | 600+ dispensaries |
Alabama launched significantly later than its neighbors — both in passing the law and in getting dispensaries operational. The four-year gap between the Hall Compassion Act (2021) and the first dispensary sales (2024) reflects the AMCC’s extended licensing process and legal challenges from unsuccessful license applicants. Despite the delays, the program is now operational and serving registered patients.